Bioeast Biotech Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Hangzhou Zhejiang China

Primary Industry

Biotechnology

About

Based in Hangzhou, China and established in 2018, Bioeast Biotech is a pharmaceutical raw material supplier dedicated to providing IVD core raw materials and overall solutions. In has a subsidiary in Hangzhou. The company acquired ISO 13485 Quality Management System Certification. In July 2023, it was awarded the title of National Specialized and New Small Giant Enterprise. In June 2024, the company closed strategic investment from new investors Heda Venture and ZJVC Venture Capital. The company mainly provides core raw materials and overall solutions. It provides core raw materials such as antigens, antibodies, enzymes, quality control products, nano-microspheres, etc. Bioeast also provides nanometre microspheres, immunodiagnostics, purification media, and molecular products. The immunodiagnostics include antigens and antibodies, enzymes and proteins, and pet diagnosis. The molecular products include nucleic acid purification series, PCR (Polymerase Chain Reaction) series, qPCR (Quantitative PCR) series, and reverse transcription series. The company also provides IVD companies with comprehensive solutions for POCT (Point-of-Care Testing), immunoturbidimetry, chemiluminescence and other products. The company generates revenue by providing core raw materials and overall solutions such as nanometre microspheres, immunodiagnostics, purification media, and molecular products.

Current Investors

YuanBio Venture, Co-Win Ventures, China Growth Capital

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Healthcare IT, Pharmaceuticals, Nanomaterials, Biomaterials

Website

www.bioeast.com

Verticals

HealthTech, Nanotechnology

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.